The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

資產類別

Equity

發行機構

Invesco

註冊地

US

成立日期

2005年6月23日

持股數量

29

ISIN

US46137V6627